Get the Stockscreener App
0.904
0.49%
0.0147
Talphera Inc stock is traded at $0.904, with a volume of 15,766.
It is up +0.49% in the last 24 hours and up +14.58% over the past month.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
See More
Previous Close:
$0.8894
Open:
$0.94
24h Volume:
15,766
Relative Volume:
0.18
Market Cap:
$15.11M
Revenue:
$2.82M
Net Income/Loss:
$-14.20M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
$-15.13M
1W Performance:
-6.90%
1M Performance:
+14.58%
6M Performance:
-12.38%
1Y Performance:
+0.00%
1-Day Range:
$0.88
$0.94
1-Week Range:
$0.87
$0.9999
52-Week Range:
$0.7111
$1.61
Talphera Inc Stock (TLPH) Company Profile
Talphera Inc Stock (TLPH) Latest News
Talphera, Inc. (NASDAQ:TLPH) Sees Large Decline in Short Interest - Defense World
Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit - Citizentribune
Talphera extends agreement deadline with Nantahala Management By Investing.com - Investing.com Australia
Talphera extends agreement deadline with Nantahala Management - Investing.com
Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Kilgore News Herald
Talphera CEO Vincent J. Angotti buys $7.6k in company stock - Investing.com
Credit Suisse gives an Underperform recommendation for Talphera Inc. (TLPH) - Knox Daily
TLPH Stock Earnings: Talphera Beats EPS for Q2 2024 - MSN
Talphera starts key trial for anticoagulant nafamostat - Investing.com India
Talphera starts key trial for anticoagulant nafamostat By Investing.com - Investing.com Canada
Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit - PR Newswire
Talphera First Half 2024 Earnings: US$0.31 loss per share (vs US$0.40 loss in 1H 2023) - Yahoo Finance
Talphera Inc (TLPH) Q2 2024 Earnings Call Transcript Highlights: Strategic Advancements and Financial Adjustments - GuruFocus.com
Talphera: Q2 Earnings Snapshot - San Antonio Express-News
Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update - Longview News-Journal
Talphera, Inc. (NASDAQ:TLPH) Q2 2024 Earnings Call Transcript - MSN
Talphera Announces CMO Retirement and Successor Appointment - TipRanks
Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate Update - PR Newswire
Comparing Talphera (NASDAQ:TLPH) and Altimmune (NASDAQ:ALT) - Defense World
Talphera (TLPH) to Release Earnings on Wednesday - Defense World
Talphera to Host Second Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, August 14, 2024 - Longview News-Journal
Talphera, Inc. (NASDAQ:TLPH) Short Interest Down 20.8% in July - Defense World
TLPH (Talphera) Cash-to-Debt : No Debt - GuruFocus.com
Short Interest in Talphera, Inc. (NASDAQ:TLPH) Drops By 16.9% - Defense World
Talphera secures shareholder nod for executive compensation plans By Investing.com - Investing.com India
Talphera Shareholders Affirm Leadership and Financial Strategy - TipRanks
Atlassian's president sells shares worth $121600 By Investing.com - Investing.com
UCB shares target raised on strong product launches, rated Overweight By Investing.com - Investing.com Australia
Talphera Inc. [TLPH] Investment Guide: What You Need to Know – Knox Daily - Knox Daily
Quarterly Snapshot: Quick and Current Ratios for Talphera Inc. (TLPH) – DWinneX - The Dwinnex
Talphera Inc. (TLPH) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
Talphera CEO Angotti buys shares worth $9856 By Investing.com - Investing.com Canada
Talphera CEO Angotti buys shares worth $9856 - Investing.com India
Short Interest in Talphera, Inc. (NASDAQ:TLPH) Drops By 17.7% - Defense World
PELOTON INTERACTIVE, INC. ANNOUNCES LAUNCH OF GLOBAL REFINANCING - The Malaysian Reserve
Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Citizentribune
Talphera (NASDAQ:TLPH) Earns “Buy” Rating from HC Wainwright - Defense World
Brokers Offer Predictions for Talphera, Inc.'s Q2 2024 Earnings (NASDAQ:TLPH) - Defense World
scPharmaceuticals (NASDAQ:SCPH) Rating Reiterated by HC Wainwright - Defense World
Apple Inc. (NASDAQ:AAPL) Shares Sold by Archer Investment Corp - Defense World
Talphera to Participate at A.G.P. Virtual Healthcare Conference - Citizentribune
CVPR Technical Program Features Presentations on the Latest AI and Computer Vision Research for Healthcare ... - The Malaysian Reserve
Composite Doors and Windows Global Business Report 2024: As Demand Rises for Hygienic Doors & Windows ... - Yahoo Canada Finance
Global Automatic Palletizer and Depalletizer Industry Report 2024: Market Poised for Growth, Set to Reach $1.60 ... - Yahoo Finance UK
Global Breast Implant Market Projected to Reach US$ 4.1 Billion by 2032 - Yahoo Finance UK
Exploring TSX Dividend Stocks In May 2024 - Yahoo Finance UK
Talphera Inc Stock (TLPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Talphera Inc Stock (TLPH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Angotti Vincent J. | CHIEF EXECUTIVE OFFICER |
Jun 13 '24 |
Buy |
0.97 |
4,570 |
4,438 |
179,502 |
| Angotti Vincent J. | CHIEF EXECUTIVE OFFICER |
Jun 12 '24 |
Buy |
0.97 |
4,126 |
4,013 |
174,932 |
| Angotti Vincent J. | CHIEF EXECUTIVE OFFICER |
Jun 14 '24 |
Buy |
1.08 |
1,304 |
1,404 |
180,806 |
| Angotti Vincent J. | Chief Executive Officer |
Dec 13 '23 |
Buy |
0.73 |
10,000 |
7,268 |
101,805 |
1.16%
1.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):